Daratumumab for Severe Refractory Anti-NMDA Receptor Encephalitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Frontiers in Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Case Report: Daratumumab in a Patient With Severe Refractory Anti-NMDA Receptor Encephalitis
Front Neurol 2020 Feb 01;11(xx)602102, D Ratuszny, T Skripuletz, F Wegner, M Groß, C Falk, R Jacobs, H Ruschulte, M Stangel, KW SühsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.